Analystreport

VBI Vaccines Inc. (NASDAQ: VBIV) had its price target lowered by analysts at Raymond James from $9.00 to $6.00. They now have a "strong-buy" rating on the stock.

VBI Vaccines, Inc. - Ordinary Shares  (VBIV) 
Last vbi vaccines, inc. - ordinary shares earnings: 11/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: vbivaccines.com/investors